
E-prescribing Market Analysis and Forecast to 2033: By Type (Integrated, Standalone), Services (Support, Implementation, Training, Network), Delivery Mode (Cloud-Based, On-Premise), Specialty (Cardiology, Oncology, Neurology, General Medicine, Others), De
Description
E-prescribing Market Analysis and Forecast to 2033: By Type (Integrated, Standalone), Services (Support, Implementation, Training, Network), Delivery Mode (Cloud-Based, On-Premise), Specialty (Cardiology, Oncology, Neurology, General Medicine, Others), Deployment Mode (Web-Based, Mobile-Based), Prescription Type (Controlled Substances, Non-Controlled Substances), Application (Medication Management, Prescription Order Management, Clinical Decision Support, Real-Time Prescription Benefit), End-User (Hospitals, Clinics, Pharmacies, Ambulatory Surgical Centers), and Region
The E-prescribing market is a critical segment in the digital transformation of healthcare, facilitating the electronic generation and sending of prescription orders. This technology aims to improve the accuracy, efficiency, and convenience of the prescribing process, thereby enhancing patient safety and compliance. E-prescribing systems are integrated with other medical and pharmacy systems, ensuring that prescriptions are transmitted directly to pharmacies in a readable format, thus minimizing errors associated with handwritten prescriptions. The E-prescribing Market was USD 1,466.8 million in 2023 and is anticipated to reach USD 15,053.3 million in 2033, growing at a rate of 18.4% from 2024 to 2033.
The proliferation of E-prescribing is driven by several factors including regulatory mandates, the push for reduced healthcare costs, and the growing adoption of electronic health records (EHRs). Governments worldwide are increasingly implementing regulations that mandate the use of E-prescribing systems to curb drug abuse, enhance the monitoring of drug dispensation, and reduce medication errors. Additionally, these systems are critical in streamlining workflows within healthcare practices, contributing to the overall reduction of administrative burdens faced by healthcare providers.
Key Trends:
- Enhanced Focus on Reducing Medication Errors: E-prescribing minimizes errors associated with traditional prescription methods, enhancing patient safety and treatment outcomes.
- Integration with Electronic Health Records (EHR): The seamless integration of e-prescribing systems with EHRs improves clinical workflows and patient data management, facilitating better healthcare delivery.
- Government Initiatives and Regulatory Support: Increasing governmental mandates and support for health IT solutions are accelerating the adoption of e-prescribing systems globally.
- Rise of Telemedicine: The expansion of telehealth practices, particularly during the COVID-19 pandemic, has driven the demand for e-prescribing as an integral component of virtual care.
- Adoption of Mobile Health Applications: The growing usage of mobile devices and apps among healthcare providers enables convenient access to e-prescribing tools, thereby enhancing the flexibility and efficiency of prescribing processes.
- Increased Regulatory Requirements: Governments worldwide are implementing stricter regulations requiring the use of e-prescribing systems to reduce medication errors and improve healthcare outcomes.
- Integration with Electronic Health Records (EHR): Seamless integration of e-prescribing systems with EHRs enhances clinical workflow efficiency, thereby driving adoption across healthcare facilities.
- Cost-Effective Healthcare Solutions: E-prescribing reduces the costs associated with traditional prescription methods, including paper and administrative expenses, which is a significant driver for its adoption.
- Rising Focus on Patient Safety and Data Security: E-prescribing systems improve patient safety by minimizing prescription errors and provide secure access to patient data, fostering trust and compliance among healthcare providers.
- Growth in Telemedicine: The expansion of telemedicine has necessitated remote prescribing capabilities, which e-prescribing platforms efficiently facilitate, thereby supporting the broader adoption of virtual healthcare services.
- Regulatory Challenges: Compliance with varying international, federal, and state regulations which dictate the use and implementation of e-prescribing systems can prove cumbersome.
- Integration and Interoperability Issues: Difficulties in integrating e-prescribing systems with existing Electronic Health Records (EHRs), leading to potential disruptions in workflow and user resistance.
- Cost Implications: The high costs associated with the implementation and maintenance of e-prescribing systems can be a significant barrier for small to medium-sized healthcare providers.
- Data Security Concerns: Persistent worries about data privacy and the risk of breaches in patient information hinder the adoption rate among healthcare providers.
- Resistance to Change: Inertia within the healthcare industry, with a preference for traditional prescribing practices over new, digital methods, slows down the adoption of e-prescribing technology.
Type (Integrated, Standalone), Services (Support, Implementation, Training, Network), Delivery Mode (Cloud-Based, On-Premise), Specialty (Cardiology, Oncology, Neurology, General Medicine, Others), Deployment Mode (Web-Based, Mobile-Based), Prescription Type (Controlled Substances, Non-Controlled Substances), Application (Medication Management, Prescription Order Management, Clinical Decision Support, Real-Time Prescription Benefit), End-User (Hospitals, Clinics, Pharmacies, Ambulatory Surgical Centers), and Region
Key Players:
The E-prescribing market include players such Surescripts, Practice Fusion, DrFirst, eClinicalWorks, Allscripts Healthcare Solutions, Cerner Corporation, Epic Systems Corporation, Athenahealth, RXNT, SureScripts-RxHub, Compulink, NextGen Healthcare, Henry Schein Medical Systems, GE Healthcare, Health Fusion, Daw Systems, Emdeon, CureMD, MTBC, and Greenway Health, among others.
Value Chain Analysis:
The value chain analysis for the E-prescribing Market can be delineated across the following five stages: Raw Material Procurement, R&D, Product Approval, Large Scale Manufacturing, and Sales and Marketing. Each stage is pivotal in ensuring the seamless flow from conception to market delivery of E-prescribing.
- Raw Material Procurement involves identifying sources of raw materials, assessing their availability, quality, and sustainability. Understanding market dynamics, pricing trends, and potential risks associated with sourcing materials is crucial. This stage also includes establishing relationships with suppliers and ensuring a steady supply of high-quality raw materials to maintain production consistency.
- R&D focuses on market analysis, trend forecasting, feasibility studies, and conducting experiments to develop new products or enhance existing ones. This stage is critical for innovation and maintaining a competitive edge. It encompasses the formulation of adhesive compounds, testing for performance under various conditions, and ensuring that the products meet the evolving needs of the market.
- Product Approval entails understanding legal requirements, industry regulations, and certification processes. This stage involves rigorous testing of products for safety, efficacy, and environmental impact. It ensures that the E-prescribing comply with national and international standards, thus facilitating smooth entry into the market. This stage also includes obtaining necessary certifications and approvals from relevant authorities.
- Large Scale Manufacturing focuses on optimizing production processes, improving efficiency, and reducing costs. This stage includes process engineering, automation technologies, and supply chain management to enhance productivity and quality. It also involves maintaining stringent quality control measures to ensure that the final products meet the desired specifications and standards.
- Sales and Marketing involves understanding customer needs, market trends, and the competitive landscape. This stage includes market segmentation, consumer behavior analysis, and branding strategies. Effective marketing campaigns, distribution channel management, and customer relationship management are essential components of this stage to drive sales and build brand loyalty. It also includes post-sales support and feedback mechanisms to continually improve the product offering.
- Estimates and forecast the overall market size for the total market, across type, application, and region
- Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
- Identify factors influencing market growth and challenges, opportunities, drivers, and restraints
- Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
- Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
- Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
- To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements
- Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives
Our research report offers comprehensive deep segmental analysis, local competitive insights, and market positioning tailored to your needs. It includes detailed local market analysis and company analysis, alongside SWOT assessments to identify strengths, weaknesses, opportunities, and threats. The report is enhanced with an Excel data dashboard for seamless analytics and efficient data crunching, providing a user-friendly interface for in-depth examination. This robust toolkit empowers businesses to make informed decisions, stay ahead of competitors, and strategically position themselves in the market.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
352 Pages
- Chapter 1: E-PRESCRIBING MARKET Overview
- 1.1 Objectives of the Study
- 1.2 E-PRESCRIBING MARKET Definition and Scope of the Report
- 1.3 Report Limitations
- 1.4 Years & Currency Considered in the Study
- 1.5 Research Methodologies
- 1.5.1 Secondary Research
- 1.5.2 Primary Research
- 1.5.3 Market Size Estimation: Top-Down Approach
- 1.5.4 Market Size Estimation: Bottom-Up Approach
- 1.5.5 Data Triangulation and Validation
- Chapter 2: Executive Summary
- 2.1 Summary
- 2.2 Key Opinion Leaders
- 2.3 Key Highlights of the Market
- by Type
- 2.4 Key Highlights of the Market
- by Services
- 2.5 Key Highlights of the Market
- by Delivery Mode
- 2.6 Key Highlights of the Market
- by Specialty
- 2.7 Key Highlights of the Market
- by Deployment Mode
- 2.8 Key Highlights of the Market
- by Prescription Type
- 2.9 Key Highlights of the Market
- by Application
- 2.10 Key Highlights of the Market
- by End-User
- 2.11 Key Highlights of the Market
- by North America
- 2.12 Key Highlights of the Market
- by Europe
- 2.13 Key Highlights of the Market
- by Asia-Pacific
- 2.14 Key Highlights of the Market
- by Latin America
- 2.15 Key Highlights of the Market
- by Middle East
- 2.16 Key Highlights of the Market
- by Africa
- Chapter 3: Premium Insights on the Market
- 3.1 Market Attractiveness Analysis
- by Region
- 3.2 Market Attractiveness Analysis
- by Type
- 3.3 Market Attractiveness Analysis
- by Services
- 3.4 Market Attractiveness Analysis
- by Delivery Mode
- 3.5 Market Attractiveness Analysis
- by Specialty
- 3.6 Market Attractiveness Analysis
- by Deployment Mode
- 3.7 Market Attractiveness Analysis
- by Prescription Type
- 3.8 Market Attractiveness Analysis
- by Application
- 3.9 Market Attractiveness Analysis
- by End-User
- 3.10 Market Attractiveness Analysis
- by North America
- 3.11 Market Attractiveness Analysis
- by Europe
- 3.12 Market Attractiveness Analysis
- by Asia-Pacific
- 3.13 Market Attractiveness Analysis
- by Latin America
- 3.14 Market Attractiveness Analysis
- by Middle East
- 3.15 Market Attractiveness Analysis
- by Africa
- Chapter 4: E-PRESCRIBING MARKET Outlook
- 4.1 E-PRESCRIBING MARKET Segmentation
- 4.2 Market Dynamics
- 4.2.1 Market Drivers
- 4.2.1.1 Driver 1
- 4.2.1.2 Driver 2
- 4.2.2 Market Trends
- 4.2.2.1 Trend 1
- 4.2.2.2 Trend 2
- 4.2.3 Market Restraints
- 4.2.3.1 Restraint 1
- 4.2.3.2 Restraint 2
- 4.2.4 Market Opportunities
- 4.2.4.1 Opportunity 1
- 4.2.4.2 Opportunity 2
- 4.3 Porter’s Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Threat of Substitutes
- 4.3.3 Bargaining Power of Buyers
- 4.3.4 Bargaining Power of Suppliers
- 4.3.5 Competitive Rivalry
- 4.4 PESTLE Analysis
- 4.5 Value Chain Analysis
- 4.6 4Ps Model
- 4.7 ANSOFF Matrix
- Chapter 5: Market Strategy
- 5.1 Parent Market Analysis
- 5.2 Supply-Demand Analysis
- 5.3 Consumer Buying Interest
- 5.4 Case Study Analysis
- 5.5 Pricing Analysis
- 5.6 Regulatory Landscape
- 5.7 Supply Chain Analysis
- 5.8 Competition Product Analysis
- 5.9 Recent Developments
- Chapter 6: E-PRESCRIBING MARKET Size
- 6.1 E-PRESCRIBING MARKET Size
- by Value
- 6.2 E-PRESCRIBING MARKET Size
- by Volume
- Chapter 7: E-PRESCRIBING MARKET
- by Type
- 7.1 Market Overview
- 7.2 Integrated
- 7.2.1 Key Market Trends & Opportunity Analysis
- 7.2.2 Market Size and Forecast
- by Region
- 7.3 Standalone
- 7.3.1 Key Market Trends & Opportunity Analysis
- 7.3.2 Market Size and Forecast
- by Region
- Chapter 8: E-PRESCRIBING MARKET
- by Services
- 8.1 Market Overview
- 8.2 Support
- 8.2.1 Key Market Trends & Opportunity Analysis
- 8.2.2 Market Size and Forecast
- by Region
- 8.3 Implementation
- 8.3.1 Key Market Trends & Opportunity Analysis
- 8.3.2 Market Size and Forecast
- by Region
- 8.4 Training
- 8.4.1 Key Market Trends & Opportunity Analysis
- 8.4.2 Market Size and Forecast
- by Region
- 8.5 Network
- 8.5.1 Key Market Trends & Opportunity Analysis
- 8.5.2 Market Size and Forecast
- by Region
- Chapter 9: E-PRESCRIBING MARKET
- by Delivery Mode
- 9.1 Market Overview
- 9.2 Cloud-Based
- 9.2.1 Key Market Trends & Opportunity Analysis
- 9.2.2 Market Size and Forecast
- by Region
- 9.3 On-Premise
- 9.3.1 Key Market Trends & Opportunity Analysis
- 9.3.2 Market Size and Forecast
- by Region
- Chapter 10: E-PRESCRIBING MARKET
- by Specialty
- 10.1 Market Overview
- 10.2 Cardiology
- 10.2.1 Key Market Trends & Opportunity Analysis
- 10.2.2 Market Size and Forecast
- by Region
- 10.3 Oncology
- 10.3.1 Key Market Trends & Opportunity Analysis
- 10.3.2 Market Size and Forecast
- by Region
- 10.4 Neurology
- 10.4.1 Key Market Trends & Opportunity Analysis
- 10.4.2 Market Size and Forecast
- by Region
- 10.5 General Medicine
- 10.5.1 Key Market Trends & Opportunity Analysis
- 10.5.2 Market Size and Forecast
- by Region
- 10.6 Others
- 10.6.1 Key Market Trends & Opportunity Analysis
- 10.6.2 Market Size and Forecast
- by Region
- Chapter 11: E-PRESCRIBING MARKET
- by Deployment Mode
- 11.1 Market Overview
- 11.2 Web-Based
- 11.2.1 Key Market Trends & Opportunity Analysis
- 11.2.2 Market Size and Forecast
- by Region
- 11.3 Mobile-Based
- 11.3.1 Key Market Trends & Opportunity Analysis
- 11.3.2 Market Size and Forecast
- by Region
- Chapter 12: E-PRESCRIBING MARKET
- by Prescription Type
- 12.1 Market Overview
- 12.2 Controlled Substances
- 12.2.1 Key Market Trends & Opportunity Analysis
- 12.2.2 Market Size and Forecast
- by Region
- 12.3 Non-Controlled Substances
- 12.3.1 Key Market Trends & Opportunity Analysis
- 12.3.2 Market Size and Forecast
- by Region
- Chapter 13: E-PRESCRIBING MARKET
- by Application
- 13.1 Market Overview
- 13.2 Medication Management
- 13.2.1 Key Market Trends & Opportunity Analysis
- 13.2.2 Market Size and Forecast
- by Region
- 13.3 Prescription Order Management
- 13.3.1 Key Market Trends & Opportunity Analysis
- 13.3.2 Market Size and Forecast
- by Region
- 13.4 Clinical Decision Support
- 13.4.1 Key Market Trends & Opportunity Analysis
- 13.4.2 Market Size and Forecast
- by Region
- 13.5 Real-Time Prescription Benefit
- 13.5.1 Key Market Trends & Opportunity Analysis
- 13.5.2 Market Size and Forecast
- by Region
- Chapter 14: E-PRESCRIBING MARKET
- by End-User
- 14.1 Market Overview
- 14.2 Hospitals
- 14.2.1 Key Market Trends & Opportunity Analysis
- 14.2.2 Market Size and Forecast
- by Region
- 14.3 Clinics
- 14.3.1 Key Market Trends & Opportunity Analysis
- 14.3.2 Market Size and Forecast
- by Region
- 14.4 Pharmacies
- 14.4.1 Key Market Trends & Opportunity Analysis
- 14.4.2 Market Size and Forecast
- by Region
- 14.5 Ambulatory Surgical Centers
- 14.5.1 Key Market Trends & Opportunity Analysis
- 14.5.2 Market Size and Forecast
- by Region
- Chapter 15: E-PRESCRIBING MARKET
- by Region
- 15.1 Overview
- 15.2 North America
- 15.2.1 Key Market Trends and Opportunities
- 15.2.2 North America E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.3 North America E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.4 North America E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.5 North America E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.6 North America E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.7 North America E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.8 North America E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.9 North America E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.10 North America E-PRESCRIBING MARKET Size and Forecast
- by Country
- 15.2.11 The U.S.
- 15.2.11.1 The U.S. E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.11.2 The U.S. E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.11.3 The U.S. E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.11.4 The U.S. E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.11.5 The U.S. E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.11.6 The U.S. E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.11.7 The U.S. E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.11.8 The U.S. E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.11.9 Local Competition Analysis
- 15.2.11.10 Local Market Analysis
- 15.2.12 Canada
- 15.2.12.1 Canada E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.12.2 Canada E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.12.3 Canada E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.12.4 Canada E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.12.5 Canada E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.12.6 Canada E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.12.7 Canada E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.12.8 Canada E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.12.9 Local Competition Analysis
- 15.2.12.10 Local Market Analysis
- 15.2.13 Mexico
- 15.2.13.1 Mexico E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.13.2 Mexico E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.13.3 Mexico E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.13.4 Mexico E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.13.5 Mexico E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.13.6 Mexico E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.13.7 Mexico E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.13.8 Mexico E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.13.9 Local Competition Analysis
- 15.2.13.10 Local Market Analysis
- 15.2 Europe
- 15.2.1 Key Market Trends and Opportunities
- 15.2.2 Europe E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.3 Europe E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.4 Europe E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.5 Europe E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.6 Europe E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.7 Europe E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.8 Europe E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.9 Europe E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.10 Europe E-PRESCRIBING MARKET Size and Forecast
- by Country
- 15.2.11 The UK
- 15.2.11.1 The UK E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.11.2 The UK E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.11.3 The UK E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.11.4 The UK E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.11.5 The UK E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.11.6 The UK E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.11.7 The UK E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.11.8 The UK E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.11.9 Local Competition Analysis
- 15.2.11.10 Local Market Analysis
- 15.2.12 Germany
- 15.2.12.1 Germany E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.12.2 Germany E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.12.3 Germany E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.12.4 Germany E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.12.5 Germany E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.12.6 Germany E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.12.7 Germany E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.12.8 Germany E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.12.9 Local Competition Analysis
- 15.2.12.10 Local Market Analysis
- 15.2.13 France
- 15.2.13.1 France E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.13.2 France E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.13.3 France E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.13.4 France E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.13.5 France E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.13.6 France E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.13.7 France E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.13.8 France E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.13.9 Local Competition Analysis
- 15.2.13.10 Local Market Analysis
- 15.2.14 Spain
- 15.2.14.1 Spain E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.14.2 Spain E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.14.3 Spain E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.14.4 Spain E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.14.5 Spain E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.14.6 Spain E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.14.7 Spain E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.14.8 Spain E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.14.9 Local Competition Analysis
- 15.2.14.10 Local Market Analysis
- 15.2.15 Italy
- 15.2.15.1 Italy E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.15.2 Italy E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.15.3 Italy E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.15.4 Italy E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.15.5 Italy E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.15.6 Italy E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.15.7 Italy E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.15.8 Italy E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.2.15.9 Local Competition Analysis
- 15.2.15.10 Local Market Analysis
- 15.2.16 Rest of Europe
- 15.2.16.1 Rest of Europe E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.2.16.2 Rest of Europe E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.2.16.3 Rest of Europe E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.2.16.4 Rest of Europe E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.2.16.5 Rest of Europe E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.2.16.6 Rest of Europe E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.2.16.7 Rest of Europe E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.2.16.8 Rest of Europe E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.3 Asia Pacific
- 15.3.1 Key Market Trends and Opportunities
- 15.3.2 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.3.3 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.3.4 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.3.5 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.3.6 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.3.7 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.3.8 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.3.9 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.3.10 Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Country
- 15.3.11 China
- 15.3.11.1 China E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.3.11.2 China E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.3.11.3 China E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.3.11.4 China E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.3.11.5 China E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.3.11.6 China E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.3.11.7 China E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.3.11.8 China E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.3.11.9 Local Competition Analysis
- 15.3.11.10 Local Market Analysis
- 15.3.12 Japan
- 15.3.12.1 Japan E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.3.12.2 Japan E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.3.12.3 Japan E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.3.12.4 Japan E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.3.12.5 Japan E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.3.12.6 Japan E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.3.12.7 Japan E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.3.12.8 Japan E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.3.12.9 Local Competition Analysis
- 15.3.12.10 Local Market Analysis
- 15.3.13 India
- 15.3.13.1 India E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.3.13.2 India E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.3.13.3 India E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.3.13.4 India E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.3.13.5 India E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.3.13.6 India E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.3.13.7 India E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.3.13.8 India E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.3.13.9 Local Competition Analysis
- 15.3.13.10 Local Market Analysis
- 15.3.14 Rest of Asia Pacific
- 15.3.14.1 Rest of Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.3.14.2 Rest of Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.3.14.3 Rest of Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.3.14.4 Rest of Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.3.14.5 Rest of Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.3.14.6 Rest of Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.3.14.7 Rest of Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.3.14.8 Rest of Asia Pacific E-PRESCRIBING MARKET Size and Forecast
- by End-User
- 15.4 Rest of the World
- 15.4.1 Key Market Trends and Opportunities
- 15.4.2 Rest of the World E-PRESCRIBING MARKET Size and Forecast
- by Type
- 15.4.3 Rest of the World E-PRESCRIBING MARKET Size and Forecast
- by Services
- 15.4.4 Rest of the World E-PRESCRIBING MARKET Size and Forecast
- by Delivery Mode
- 15.4.5 Rest of the World E-PRESCRIBING MARKET Size and Forecast
- by Specialty
- 15.4.6 Rest of the World E-PRESCRIBING MARKET Size and Forecast
- by Deployment Mode
- 15.4.7 Rest of the World E-PRESCRIBING MARKET Size and Forecast
- by Prescription Type
- 15.4.8 Rest of the World E-PRESCRIBING MARKET Size and Forecast
- by Application
- 15.4.9 Rest of the World E-PRESCRIBING MARKET Size and Forecast
- by End-User
- Chapter 16: Competitive Landscape
- 16.1 Overview
- 16.2 Market Share Analysis
- 16.3 Key Player Positioning
- 16.4 Competitive Leadership Mapping
- 16.4.1 Star Players
- 16.4.2 Innovators
- 16.4.3 Emerging Players
- 16.5 Vendor Benchmarking
- 16.6 Developmental Strategy Benchmarking
- 16.6.1 New Product Developments
- 16.6.2 Product Launches
- 16.6.3 Business Expansions
- 16.6.4 Partnerships
- Joint Ventures
- and Collaborations
- 16.6.5 Mergers and Acquisitions
- Chapter 17: Company Profiles
- 17.1 Surescripts
- 17.1.1 Company Overview
- 17.1.2 Company Snapshot
- 17.1.3 Business Segments
- 17.1.4 Business Performance
- 17.1.5 Product Offerings
- 17.1.6 Key Developmental Strategies
- 17.1.7 SWOT Analysis
- 17.2 Practice Fusion
- 17.2.1 Company Overview
- 17.2.2 Company Snapshot
- 17.2.3 Business Segments
- 17.2.4 Business Performance
- 17.2.5 Product Offerings
- 17.2.6 Key Developmental Strategies
- 17.2.7 SWOT Analysis
- 17.3 DrFirst
- 17.3.1 Company Overview
- 17.3.2 Company Snapshot
- 17.3.3 Business Segments
- 17.3.4 Business Performance
- 17.3.5 Product Offerings
- 17.3.6 Key Developmental Strategies
- 17.3.7 SWOT Analysis
- 17.4 eClinicalWorks
- 17.4.1 Company Overview
- 17.4.2 Company Snapshot
- 17.4.3 Business Segments
- 17.4.4 Business Performance
- 17.4.5 Product Offerings
- 17.4.6 Key Developmental Strategies
- 17.4.7 SWOT Analysis
- 17.5 Allscripts Healthcare Solutions
- 17.5.1 Company Overview
- 17.5.2 Company Snapshot
- 17.5.3 Business Segments
- 17.5.4 Business Performance
- 17.5.5 Product Offerings
- 17.5.6 Key Developmental Strategies
- 17.5.7 SWOT Analysis
- 17.6 Cerner Corporation
- 17.6.1 Company Overview
- 17.6.2 Company Snapshot
- 17.6.3 Business Segments
- 17.6.4 Business Performance
- 17.6.5 Product Offerings
- 17.6.6 Key Developmental Strategies
- 17.6.7 SWOT Analysis
- 17.7 Epic Systems Corporation
- 17.7.1 Company Overview
- 17.7.2 Company Snapshot
- 17.7.3 Business Segments
- 17.7.4 Business Performance
- 17.7.5 Product Offerings
- 17.7.6 Key Developmental Strategies
- 17.7.7 SWOT Analysis
- 17.8 Athenahealth
- 17.8.1 Company Overview
- 17.8.2 Company Snapshot
- 17.8.3 Business Segments
- 17.8.4 Business Performance
- 17.8.5 Product Offerings
- 17.8.6 Key Developmental Strategies
- 17.8.7 SWOT Analysis
- 17.9 RXNT
- 17.9.1 Company Overview
- 17.9.2 Company Snapshot
- 17.9.3 Business Segments
- 17.9.4 Business Performance
- 17.9.5 Product Offerings
- 17.9.6 Key Developmental Strategies
- 17.9.7 SWOT Analysis
- 17.10 SureScripts-RxHub
- 17.10.1 Company Overview
- 17.10.2 Company Snapshot
- 17.10.3 Business Segments
- 17.10.4 Business Performance
- 17.10.5 Product Offerings
- 17.10.6 Key Developmental Strategies
- 17.10.7 SWOT Analysis
- 17.11 Compulink
- 17.11.1 Company Overview
- 17.11.2 Company Snapshot
- 17.11.3 Business Segments
- 17.11.4 Business Performance
- 17.11.5 Product Offerings
- 17.11.6 Key Developmental Strategies
- 17.11.7 SWOT Analysis
- 17.12 NextGen Healthcare
- 17.12.1 Company Overview
- 17.12.2 Company Snapshot
- 17.12.3 Business Segments
- 17.12.4 Business Performance
- 17.12.5 Product Offerings
- 17.12.6 Key Developmental Strategies
- 17.12.7 SWOT Analysis
- 17.13 Henry Schein Medical Systems
- 17.13.1 Company Overview
- 17.13.2 Company Snapshot
- 17.13.3 Business Segments
- 17.13.4 Business Performance
- 17.13.5 Product Offerings
- 17.13.6 Key Developmental Strategies
- 17.13.7 SWOT Analysis
- 17.14 GE Healthcare
- 17.14.1 Company Overview
- 17.14.2 Company Snapshot
- 17.14.3 Business Segments
- 17.14.4 Business Performance
- 17.14.5 Product Offerings
- 17.14.6 Key Developmental Strategies
- 17.14.7 SWOT Analysis
- 17.15 Health Fusion
- 17.15.1 Company Overview
- 17.15.2 Company Snapshot
- 17.15.3 Business Segments
- 17.15.4 Business Performance
- 17.15.5 Product Offerings
- 17.15.6 Key Developmental Strategies
- 17.15.7 SWOT Analysis
- 17.16 Daw Systems
- 17.16.1 Company Overview
- 17.16.2 Company Snapshot
- 17.16.3 Business Segments
- 17.16.4 Business Performance
- 17.16.5 Product Offerings
- 17.16.6 Key Developmental Strategies
- 17.16.7 SWOT Analysis
- 17.17 Emdeon
- 17.17.1 Company Overview
- 17.17.2 Company Snapshot
- 17.17.3 Business Segments
- 17.17.4 Business Performance
- 17.17.5 Product Offerings
- 17.17.6 Key Developmental Strategies
- 17.17.7 SWOT Analysis
- 17.18 CureMD
- 17.18.1 Company Overview
- 17.18.2 Company Snapshot
- 17.18.3 Business Segments
- 17.18.4 Business Performance
- 17.18.5 Product Offerings
- 17.18.6 Key Developmental Strategies
- 17.18.7 SWOT Analysis
- 17.19 MTBC
- 17.19.1 Company Overview
- 17.19.2 Company Snapshot
- 17.19.3 Business Segments
- 17.19.4 Business Performance
- 17.19.5 Product Offerings
- 17.19.6 Key Developmental Strategies
- 17.19.7 SWOT Analysis
- 17.20 Greenway Health
- 17.20.1 Company Overview
- 17.20.2 Company Snapshot
- 17.20.3 Business Segments
- 17.20.4 Business Performance
- 17.20.5 Product Offerings
- 17.20.6 Key Developmental Strategies
- 17.20.7 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.